已发表论文

临床神经修复在帕金森氏病 (Parkinson's disease) 治疗中的进展

 

Authors Chen L, Huang HY, Duan WM, Mao GS

Published Date June 2015 Volume 2015:3 Pages 101—107

DOI http://dx.doi.org/10.2147/JN.S74144

Received 26 September 2014, Accepted 30 January 2015, Published 30 June 2015

Approved for publication by Prof. Dr. Hari Shanker Sharma

Abstract: Parkinson’s disease (PD) is one of the common neurodegenerative diseases. Besides the symptomatic therapies, the increasing numbers of neurorestorative therapies have shown the potential therapeutic value of reversing the neurodegenerative process and improving the patient's quality of life. Currrently available novel clinical neurorestorative strategies include pharmacological managements (glial cell-line derived neurotrophic factor, selegiline, recombinant human erythropoietin), neuromodulation intervention (deep brain stimulation, repetitive transcranial magnetic stimulation, transcranial direct current stimulation), tissue and cell transplantation (fetal ventral mesencephalic tissue, sympathetic neurons, carotid body cells, bone marrow stromal cells, retinal pigment epithelium cells), gene therapy, and neurorehabilitative therapy. Herein, we briefly review the progress in this field and describe the neurorestorative mechanisms of the above-mentioned therapies for PD.
Keywords: Parkinson’s disease, clinical study, neurorestorative treatment, cell transplantation, neuromodulation